410 related articles for article (PubMed ID: 25917125)
1. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
[TBL] [Abstract][Full Text] [Related]
2. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
Holmén E; Warnqvist A; Kåberg M
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
[TBL] [Abstract][Full Text] [Related]
3. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
Front Public Health; 2022; 10():811001. PubMed ID: 35359781
[TBL] [Abstract][Full Text] [Related]
5. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
Ericson ØB; Eide D; Lobmaier P; Clausen T
Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
[TBL] [Abstract][Full Text] [Related]
6. Naloxone distribution and possession following a large-scale naloxone programme.
Madah-Amiri D; Gjersing L; Clausen T
Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
[TBL] [Abstract][Full Text] [Related]
7. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
[TBL] [Abstract][Full Text] [Related]
8. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
9. Brief overdose education is sufficient for naloxone distribution to opioid users.
Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
[TBL] [Abstract][Full Text] [Related]
11. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
[TBL] [Abstract][Full Text] [Related]
12. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
13. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
14. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
15. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
Katzman JG; Takeda MY; Bhatt SR; Moya Balasch M; Greenberg N; Yonas H
J Addict Med; 2018; 12(2):113-118. PubMed ID: 29227321
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
[TBL] [Abstract][Full Text] [Related]
18. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
[TBL] [Abstract][Full Text] [Related]
19. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
[TBL] [Abstract][Full Text] [Related]
20. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
